Literature DB >> 18603413

Increased absolute magnitude of gamma synchrony in first-episode psychosis.

Gary Flynn1, David Alexander, Anthony Harris, Thomas Whitford, Wilson Wong, Cherrie Galletly, Steve Silverstein, Evian Gordon, Leanne M Williams.   

Abstract

OBJECTIVES: Recent studies have explored a model of the disconnection hypothesis of schizophrenia through the demonstration of abnormal stimulus induced gamma phase synchrony (GPS). These studies have principally examined synchrony in the 40 Hz band elicited in post-stimulus time periods, relative to a pre-stimulus baseline. In this study we examined the absolute magnitude of GPS elicited by a selective attention task, in first-episode psychosis (FEP). We hypothesized that FEP would be associated with abnormalities in absolute GPS, particularly when required to selectively attend to task-relevant stimuli.
METHODS: Fifty-five first-episode psychosis (FEP) subjects and one hundred and ten matched healthy control subjects underwent an auditory oddball selective attention task during EEG recording. The absolute magnitude of GPS was extracted for the range 35-45 Hz, and time-locked to stimulus onset. GPS averaged were computed for oddball 'target' (task-relevant) and 'non-target' (task-irrelevant) stimuli, for each subject.
RESULTS: FEP subjects showed a significant elevation in absolute GPS relative to controls, apparent across the 35-45 Hz range. This elevation was most marked in the left centro-temporal region, across the 800 ms post-stimulus period. In FEP subjects, the elevation in GPS was also greater for target compared to non-target stimuli, while healthy controls did not show a stimulus effect.
CONCLUSION: These findings complement previous evidence for reductions in peak gamma synchrony, calculated relative to a pre-stimulus baseline, in schizophrenia. The results an excess of absolute GPS in schizophrenia may contribute to an inability to effectively integrate task-relevant information, which underlie psychotic symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 18603413     DOI: 10.1016/j.schres.2008.05.029

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

Review 1.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

2.  Acute administration of typical and atypical antipsychotics reduces EEG γ power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in γ power.

Authors:  Nigel C Jones; Maya Reddy; Paul Anderson; Michael R Salzberg; Terence J O'Brien; Didier Pinault
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-09       Impact factor: 5.176

3.  Transcranial direct current stimulation over the sensory-motor regions inhibits gamma synchrony.

Authors:  Giovanni Pellegrino; Giorgio Arcara; Giovanni Di Pino; Cristina Turco; Matteo Maran; Luca Weis; Francesco Piccione; Hartwig Roman Siebner
Journal:  Hum Brain Mapp       Date:  2019-03-10       Impact factor: 5.038

4.  A shared low-frequency oscillatory rhythm abnormality in resting and sensory gating in schizophrenia.

Authors:  L Elliot Hong; Ann Summerfelt; Braxton D Mitchell; Patricio O'Donnell; Gunvant K Thaker
Journal:  Clin Neurophysiol       Date:  2011-09-08       Impact factor: 3.708

5.  Electroencephalography Spectral Power Density in First-Episode Mania: A Comparative Study with Subsequent Remission Period.

Authors:  Sertaç Güven; Sermin Kesebir; R Murat Demirer; Mustafa Bilici
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

6.  Disrupted cholinergic modulation can underlie abnormal gamma rhythms in schizophrenia and auditory hallucination.

Authors:  Jung Hoon Lee
Journal:  J Comput Neurosci       Date:  2017-10-18       Impact factor: 1.621

Review 7.  Aberrant Network Activity in Schizophrenia.

Authors:  Mark J Hunt; Nancy J Kopell; Roger D Traub; Miles A Whittington
Journal:  Trends Neurosci       Date:  2017-05-14       Impact factor: 13.837

8.  Human depression: a new approach in quantitative psychiatry.

Authors:  Massimo Cocchi; Lucio Tonello; Mark M Rasenick
Journal:  Ann Gen Psychiatry       Date:  2010-06-03       Impact factor: 3.455

9.  Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Authors:  L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

Review 10.  The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.